PMID- 20038396
OWN - NLM
STAT- MEDLINE
DCOM- 20100608
LR  - 20191111
IS  - 1130-6343 (Print)
IS  - 1130-6343 (Linking)
VI  - 33
IP  - 6
DP  - 2009 Nov-Dec
TI  - [Controversy regarding the concomitant use of clopidogrel and proton pump 
      inhibitors (PPI)].
PG  - 339-40
FAU - Calderon Hernanz, Beatriz
AU  - Calderon Hernanz B
FAU - Pinteno Blanco, Manel
AU  - Pinteno Blanco M
FAU - Puigventos Latorre, Francesc
AU  - Puigventos Latorre F
FAU - Martinez Lopez, Iciar
AU  - Martinez Lopez I
LA  - spa
PT  - Comment
PT  - Letter
TT  - Controversia acerca del uso concomitante de clopidogrel e inhibidores de la bomba 
      de protones.
PL  - Spain
TA  - Farm Hosp
JT  - Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad 
      Espanola de Farmacia Hospitalaria
JID - 9440679
RN  - 0 (Histamine H2 Antagonists)
RN  - 0 (Platelet Aggregation Inhibitors)
RN  - 0 (Proton Pump Inhibitors)
RN  - 0 (Pyridines)
RN  - 0 (thienopyridine)
RN  - A74586SNO7 (Clopidogrel)
RN  - OM90ZUW7M1 (Ticlopidine)
SB  - IM
CON - Farm Hosp. 2009 Nov-Dec;33(6):338-9. PMID: 20038395
MH  - Clinical Trials as Topic
MH  - Clopidogrel
MH  - Contraindications
MH  - Drug Interactions
MH  - Histamine H2 Antagonists/administration & dosage/therapeutic use
MH  - Humans
MH  - Meta-Analysis as Topic
MH  - Multicenter Studies as Topic
MH  - Platelet Aggregation Inhibitors/adverse effects/*pharmacokinetics/therapeutic use
MH  - Practice Guidelines as Topic
MH  - Proton Pump Inhibitors/adverse effects/*pharmacokinetics/therapeutic use
MH  - Pyridines/adverse effects/*pharmacokinetics/therapeutic use
MH  - Ticlopidine/adverse effects/*analogs & derivatives/pharmacokinetics/therapeutic 
      use
EDAT- 2009/12/30 06:00
MHDA- 2010/06/09 06:00
CRDT- 2009/12/30 06:00
PHST- 2009/12/30 06:00 [entrez]
PHST- 2009/12/30 06:00 [pubmed]
PHST- 2010/06/09 06:00 [medline]
AID - S1130-6343(09)72980-0 [pii]
AID - 10.1016/s1130-6343(09)72980-0 [doi]
PST - ppublish
SO  - Farm Hosp. 2009 Nov-Dec;33(6):339-40. doi: 10.1016/s1130-6343(09)72980-0.